U.S. Global Investors (USGI)’s Medifast MED Stock Holding History

U.S. Global Investors (USGI)’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-9,566	Closed	-$1.05M	–	185
2019 Q4	$1.05M	Buy	9,566 +1,717	+22%	+$166K	0.47%	65
2019 Q3	$813K	Buy	7,849 +241	+3%	+$25.9K	0.44%	72
2019 Q2	$976K	Buy	7,608 +3,035	+66%	+$422K	0.5%	56
2019 Q1	$583K	Buy	+4,573	New	+$580K	0.28%	82
2018 Q3	–	Sell	-8,800	Closed	-$1.41M	–	164
2018 Q2	$1.41M	Sell	8,800 -8,800	-50%	-$1.13M	0.64%	41
2018 Q1	$1.65M	Sell	17,600 -10,900	-38%	-$814K	1.01%	21
2017 Q4	$1.99M	Buy	+28,500	New	+$1.89M	0.91%	21

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

U.S. Global Investors (USGI)'s MED Position: Q1 2020 in Review

U.S. Global Investors (USGI) sold out of Medifast (MED) in Q1 2020, closing a stake of 9,566 shares — an estimated $1.05M sold.

U.S. Global Investors (USGI) first reported a position in MED in Q4 2017 and held it in 7 quarters. The position peaked at $1.99M in Q4 2017. 201 funds tracked by Wall St. Rank hold MED as of Q1 2020.

U.S. Global Investors (USGI) reported no remaining Medifast position as of Q1 2020 after selling out during the quarter.
U.S. Global Investors (USGI) sold 9,566 Medifast shares in Q1 2020, an estimated $1.05M.
U.S. Global Investors (USGI) first reported a position in Medifast in Q4 2017 and held it in 7 quarters.
U.S. Global Investors (USGI)'s Medifast position peaked at $1.99M in Q4 2017.
201 funds tracked by Wall St. Rank held Medifast as of Q1 2020.

Based on U.S. Global Investors (USGI)'s 13F filing for Q1 2020, filed 4 May 2020.